COMMUNIQUÉS West-GlobeNewswire

XBiotech annonce l'interruption de l'étude de phase III pour le cancer colorectal sur la base de la deuxième analyse intermédiaire
12/06/2017
AUSTIN, Texas, le 9 juin 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ:XBIT) a annoncé aujourd'hui qu'un Comité indépendant de surveillance et de suivi des données (IDMC) a réalisé une analyse prospective sans insu de l [...]
Ossur Hf : Transactions in relation to share buyback program
12/06/2017
Announcement from Össur hf. No. 44/2017 Reykjavík, 12 June 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Diaxonhit : Nomination de Jean-Michel Carle Grandmougin en tant que Président du directoire
12/06/2017
Nomination de Jean-Michel Carle Grandmougin en tant que Président du directoire de Diaxonhit Paris, France - 12 juin 2017 - DIAXONHIT (FR0004054427, ALEHT, éligible PEA-PME), groupe français leader dans le diagnostic [...]
Solon Eiendom ASA - Primary insider notification
12/06/2017
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 12 June 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company [...]
Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
12/06/2017
Novel mRNA-based antibody drug class holds promise for fast development of potent immunotherapies MAINZ, Germany, June 12, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering [...]
Prothena Announces Appointment of Wagner Zago, PhD as Chief Scientific Officer
12/06/2017
DUBLIN, Ireland, June 12, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]
ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
12/06/2017
SAN FRANCISCO, June 12, 2017 (GLOBE NEWSWIRE) -- In a late-breaking abstract at the 77 th American Diabetes Association meeting in San Diego, ProLynx LLC announced a novel drug delivery system to support once-monthly [...]
Solon Eiendom ASA : Bionor Pharma winding down operations
12/06/2017
Oslo, June 12, 2017 As previously communicated, the biopharmaceutical division engaged a team of international industry experts to propose an updated development plan and strategic partnership assessment. The team has [...]
Saniona AB: Saniona publishes prospectus for listing of shares on Nasdaq Stockholm
12/06/2017
PRESS RELEASE 12 June 2017 Saniona AB (publ) ("Saniona" or the "Company") has prepared a prospectus for admission to trading of the Company's shares at Nasdaq Stockholm. Last day of trading at Nasdaq First North Premier [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
12/06/2017
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
12/06/2017
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
12/06/2017
FIT Biotech Oy Company release June 12, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Zealand to regain control of elsiglutide
12/06/2017
Zealand to regain control of elsiglutide Helsinn returns elsiglutide to Zealand Zealand now has full rights to develop products within cancer-supportive care Lugano, Switzerland and Copenhagen, Denmark, June 12, 2017 - [...]
Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan
12/06/2017
Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan Herantis Pharma Plc Company release 12 June 2017 at 9:00 am Finnish Medicines Agency Fimea has [...]
Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX®
12/06/2017
Press Release 12 June 2017 Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX® --New Designation is One of the First Cell-based Therapy Names Established by the [...]
Basilea announces clinical study agreement with Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma
12/06/2017
The Adult Brain Tumor Consortium (ABTC) is designed to develop more effective treatments for malignant brain tumors. It is funded by the US National Cancer Institute (NCI). The ABTC will conduct a clinical phase 1 study [...]
TiGenix announces final equity payment for cardiac platform acquisition
12/06/2017
PRESS R ELEASE regulated information Leuven (BELGIUM) - June 12, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory [...]
TiGenix annonce le paiement final en actions pour l'acquisition de sa plateforme cardiaque
12/06/2017
Communiqué de Presse Information réglementée Louvain (BELGIQUE) - 12 juin 2017, 7:00 h CEST - TiGenix NV (Euronext Brussels et NASDAQ: TIG), une société biopharmaceutique de pointe spécialisée dans l'exploration de [...]
Probiodrug announces encouraging results of the Phase 2a SAPHIR Study
11/06/2017
Probiodrug announces encouraging results of the Phase 2a SAPHIR Study HALLE (SAALE), Germany, 11 June 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to [...]

Pages